BAC Research Update — July 7, 2026
Updated Thesis
Bank of America Corporation operates as a diversified bank within the financial services sector, offering a broad range of banking and financial products. The business quality is medium, supported by a solid 10.5% return on equity and healthy margins including a 63.2% gross margin and 18.1% net margin. However, the company faces significant headwinds as revenue declined 35.6% year-over-year in the most recent quarter, despite earnings growth of 16.1% in the same period.
The investment grade as of this refresh is C — average business quality. Medium-tier business, expensive valuation with 45.0% downside to $32.95 fair value
Key Metrics at a Glance
- Revenue growth: -35.6% year over year
- Net margin: 18.1%
- Forward P/E: 14.7x
- Fair value upside: -45.0% to our estimate of $33
Current price: $59.90
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Bank of America Corporation remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full BAC research →](/stocks/BAC)